Chemical Intervention of Influenza Virus mRNA Nuclear Export

dc.contributor.advisorShay, Jerry W.en
dc.contributor.committeeMemberFontoura, Beatrizen
dc.contributor.committeeMemberGrinnell, Fredericken
dc.contributor.committeeMemberMinna, John D.en
dc.creatorEsparza, Matthew Aaronen
dc.creator.orcid0000-0001-5277-0398
dc.date.accessioned2020-09-01T21:10:29Z
dc.date.available2020-09-01T21:10:29Z
dc.date.created2020-08
dc.date.issued2020-07-15
dc.date.submittedAugust 2020
dc.date.updated2020-09-01T21:10:29Z
dc.description.abstractInfluenza A viruses are human pathogens with limited therapeutic options, making it crucial to devise strategies for the identification of new classes of antiviral medications. The influenza A virus genome is constituted of 8 RNA segments. Two of these viral RNAs are transcribed into mRNAs that are alternatively spliced. The M1 mRNA encodes the M1 protein but is also alternatively spliced to yield the M2 mRNA during infection. M1 to M2 mRNA splicing occurs at nuclear speckles, and M1 and M2 mRNAs are exported to the cytoplasm for translation. M1 and M2 proteins are critical for viral trafficking, assembly, and budding. We show that influenza virus utilizes nuclear speckles to promote post-transcriptional splicing of its M1 mRNA. We assign previously unknown roles for the viral NS1 protein and cellular factors to an intranuclear trafficking pathway that targets the viral M1 mRNA to nuclear speckles, mediates splicing at these nuclear bodies, and exports the spliced M2 mRNA from the nucleus. In addition, gene knockout of the cellular protein NS1-BP, a constituent of the M mRNA speckle-export pathway, inhibits M mRNA nuclear export without significantly altering bulk cellular mRNA export, providing an avenue to preferentially target influenza virus. We performed a high-content, image-based chemical screen using single-molecule RNA-FISH to label viral M mRNAs followed by multistep quantitative approaches to assess cellular mRNA and cell toxicity. We identified inhibitors of viral mRNA biogenesis and nuclear export that exhibited no significant activity towards bulk cellular mRNA at non-cytotoxic concentrations. Among the hits is a small molecule that inhibits nuclear export of a subset of viral and cellular mRNAs via the mRNA export factor UAP56 without altering bulk cellular mRNA nuclear export. These findings underscore specific nuclear export requirements for viral mRNA nuclear export. This RNA export inhibitor also impaired replication of diverse influenza virus strains at non-toxic concentrations. Thus, this screening strategy yielded compounds that alone or in combination may serve as leads to new ways of treating influenza virus infection and are novel tools for studying viral RNA trafficking in the nucleus.en
dc.format.mimetypeapplication/pdfen
dc.identifier.oclc1192326112
dc.identifier.urihttps://hdl.handle.net/2152.5/8811
dc.language.isoenen
dc.subjectActive Transport, Cell Nucleusen
dc.subjectInfluenza A virusen
dc.subjectRNA Splicingen
dc.subjectRNA, Messengeren
dc.subjectRNA, Viralen
dc.subjectTranscription Factorsen
dc.titleChemical Intervention of Influenza Virus mRNA Nuclear Exporten
dc.typeThesisen
dc.type.materialtexten
thesis.degree.departmentGraduate School of Biomedical Sciencesen
thesis.degree.disciplineCancer Biologyen
thesis.degree.grantorUT Southwestern Medical Centeren
thesis.degree.levelDoctoralen
thesis.degree.nameDoctor of Philosophyen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ESPARZA-DISSERTATION-2020.pdf
Size:
4.03 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
LICENSE.txt
Size:
1.84 KB
Format:
Plain Text
Description: